Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 222
Selected: 0
NCT IDTitle
NCT07138885A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma
NCT07560449QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms
NCT03244085A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients
NCT05932888Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects
NCT03750916Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer
NCT05543343Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
NCT05052567CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
NCT06942767Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
NCT07138833A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)
NCT06007586Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
NCT07124468Assess the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Meropenem-Pralubactam (Meropenem/FL058) in China Healthy Adult Participants
NCT07040826Lifitegrast Eye Drops in Healthy Subjects:Phase I Study
NCT05576272A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma
NCT07040228A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer
NCT03381430Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR
NCT05058105Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)
NCT06880276Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT05703204A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT05555212To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation
NCT05860530Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers
NCT06954246A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06994507GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
NCT05055687Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)
NCT07489612QLS1410 in Participants With Uncontrolled Hypertension
NCT04705519Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine Carcinoma
NCT07173556A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer
NCT07018050Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
NCT02335879Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
NCT05461287Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors
NCT07138209A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT06616571Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
NCT07152444A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension
NCT04435652A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.
NCT05920876A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma
NCT07358884First in Human Study of QLS5316 in Solid Tumors
NCT05554913Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia
NCT07151872Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer
NCT04213105Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
NCT05823285A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients
NCT04550949To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors
NCT06686576A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
NCT04157699An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b
NCT07416058PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC
NCT07453394QLS5132 Combination Therapy in Advanced Solid Tumors
NCT07331545Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults
NCT05690945A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer
NCT03727295Idebenone Treatment of Early Parkinson's Diseasesymptoms
NCT05801107Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
NCT04651036A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects
NCT05950516Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes